Medline (MDLN) Stock Forecast: StockMap's 2-Week Call

MDLN stock forecast: StockMap's model makes no two-week call on Medline after the Nov 19 close: its evidence is split, 7 reasons for and 8 against. Right in 2 of 5 two-week windows on MDLN since Aug 21; by chance, a call on the same dates was right 63% of the time.

Medline last closed at $37.84, -3.37% on the session.

Against the IVW growth benchmark the position is -1.04% over the forecast window.

Medline's market cap is $49.77B as of November 19, 2026.

No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -3 (too close to call).

Where MDLN sits: sized by market cap, coloured by the day's move.

The read is built from 15 underlying insights — 7 bullish and 8 bearish.

Agreement across those insights is 53%.

30 daily calls for MDLN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Medline in the 10th percentile on valuation and the 47th percentile on return on equity, where 100 is best.

Medline is classified under Health Care / Health Care Equipment & Supplies.

StockMap tracks Medline as the 9th largest of the 141 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 69 Neutral, 55 Moderate Underperform, 14 Strong Underperform and 3 Moderate Outperform.

On that composite Medline ranks 34th of 141 in the group, against a group median of -0.18.

Other Health Care stocks

Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 19, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.

Medline (MDLN) — StockMap 2-week forecast & tracked accuracy